- Home
- ONC
as 05-08-2025 4:00pm EST
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
| Founded: | 2010 | Country: | Cayman Islands |
| Employees: | N/A | City: | GRAND CAYMAN |
| Market Cap: | 26.9B | IPO Year: | N/A |
| Target Price: | $326.43 | AVG Volume (30 days): | 502.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $141.31 - $287.88 | Next Earning Date: | 05-07-2025 |
| Revenue: | $4,175,868,000 | Revenue Growth: | 51.16% |
| Revenue Growth (this year): | 860.73% | Revenue Growth (next year): | 19.79% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
RBC Trims Price Target on BeiGene to $311 From $312, Keeps Outperform Rating
Zacks
2 days ago
Compared to Estimates, BeiGene (ONC) Q1 Earnings: A Look at Key Metrics
MT Newswires
2 days ago
Sector Update: Health Care Stocks Advance Pre-Bell Wednesday
MT Newswires
2 days ago
BeiGene Swings to Q1 Adjusted Earnings, Revenue Increases; 2025 Revenue Outlook Reiterated
Business Wire
2 days ago
BeiGene Announces First Quarter 2025 Financial Results and Business Updates
Business Wire
10 days ago
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene
Simply Wall St.
10 days ago
3 Stocks That Could Be Trading Below Their Estimated Fair Value
Investor's Business Daily
15 days ago
Will This Cancer Stock Buck Trump's Tariff Onslaught As It Nears Buy Point, Earnings?
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.